Free from Publisher

Bispecific antibody neutralizes circulating SARS-CoV-2 variants, prevents escape and protects mice from disease

R De Gasparo, M Pedotti, L Simonelli, P Nickl… - bioRxiv, 2021 - biorxiv.org
Neutralizing antibodies targeting the receptor binding domain (RBD) of the SARS-CoV-2
Spike (S) are among the most promising approaches against coronavirus disease 2019 …
被引用次数：1 相关文章

Bispecific antibody neutralizes circulating SARS-CoV-2 variants, prevents escape and protects mice from disease

R De Gasparo, M Pedotti… - … : the preprint server …, 2021 - pubmed.ncbi.nlm.nih.gov
Neutralizing antibodies targeting the receptor binding domain (RBD) of the SARS-CoV-2
Spike (S) are among the most promising approaches against coronavirus disease 2019 …

Bispecific antibody neutralizes circulating SARS-CoV-2 variants, prevents escape and protects mice from disease

R De Gasparo, M Pedotti, L Simonelli, P Nickl… - bioRxiv - ncbi.nlm.nih.gov
Neutralizing antibodies targeting the receptor binding domain (RBD) of the SARS-CoV-2
Spike (S) are among the most promising approaches against coronavirus disease 2019 …

Bispecific antibody neutralizes circulating SARS-CoV-2 variants, prevents escape and protects mice from disease.

R De Gasparo, M Pedotti, L Simonelli… - Biorxiv: the Preprint …, 2021 - europepmc.org
Neutralizing antibodies targeting the receptor binding domain (RBD) of the SARS-CoV-2
Spike (S) are among the most promising approaches against coronavirus disease 2019 …

Bispecific antibody neutralizes circulating SARS-CoV-2 variants, prevents escape and protects mice from disease

R De Gasparo, M Pedotti, L Simonelli, P Nickl… - 2021 - europepmc.org
Neutralizing antibodies targeting the receptor binding domain (RBD) of the SARS-CoV-2
Spike (S) are among the most promising approaches against coronavirus disease 2019 …